These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 15807521)

  • 1. Inhibitor and ion binding sites on the gastric H,K-ATPase.
    Munson K; Garcia R; Sachs G
    Biochemistry; 2005 Apr; 44(14):5267-84. PubMed ID: 15807521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of the K+-competitive inhibitor site of gastric H,K-ATPase.
    Vagin O; Munson K; Lambrecht N; Karlish SJ; Sachs G
    Biochemistry; 2001 Jun; 40(25):7480-90. PubMed ID: 11412101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand docking in the gastric H+/K+-ATPase: homology modeling of reversible inhibitor binding sites.
    Kim CG; Watts JA; Watts A
    J Med Chem; 2005 Nov; 48(23):7145-52. PubMed ID: 16279772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of the Na+,K+-ATPase and the H+,K+-ATPase.
    Poulsen H; Morth P; Egebjerg J; Nissen P
    FEBS Lett; 2010 Jun; 584(12):2589-95. PubMed ID: 20412804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors.
    Shin JM; Cho YM; Sachs G
    J Am Chem Soc; 2004 Jun; 126(25):7800-11. PubMed ID: 15212527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of AZD0865, a K+-competitive inhibitor of gastric H+,K+-ATPase.
    Gedda K; Briving C; Svensson K; Maxvall I; Andersson K
    Biochem Pharmacol; 2007 Jan; 73(2):198-205. PubMed ID: 17081503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gastric H,K ATPase as a drug target: past, present, and future.
    Sachs G; Shin JM; Vagin O; Lambrecht N; Yakubov I; Munson K
    J Clin Gastroenterol; 2007 Jul; 41 Suppl 2(Suppl 2):S226-42. PubMed ID: 17575528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.
    Besancon M; Simon A; Sachs G; Shin JM
    J Biol Chem; 1997 Sep; 272(36):22438-46. PubMed ID: 9278394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric H+,K+-ATPase.
    Shin JM; Munson K; Sachs G
    Compr Physiol; 2011 Oct; 1(4):2141-53. PubMed ID: 23733700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional consequences of the oligomeric form of the membrane-bound gastric H,K-ATPase.
    Shin JM; Grundler G; Senn-Bilfinger J; Simon WA; Sachs G
    Biochemistry; 2005 Dec; 44(49):16321-32. PubMed ID: 16331993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model of 3D-structure of H+, K+-ATPase catalytic subunit derived by homology modeling.
    Yan D; Hu YD; Li S; Cheng MS
    Acta Pharmacol Sin; 2004 Apr; 25(4):474-9. PubMed ID: 15066216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-directed mutagenesis of cation coordinating residues in the gastric H,K-ATPase.
    Rulli SJ; Louneva NM; Skripnikova EV; Rabon EC
    Arch Biochem Biophys; 2001 Mar; 387(1):27-34. PubMed ID: 11368180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the inhibitory activity of tenatoprazole on the gastric H+,K+ -ATPase in vitro and in vivo.
    Shin JM; Homerin M; Domagala F; Ficheux H; Sachs G
    Biochem Pharmacol; 2006 Mar; 71(6):837-49. PubMed ID: 16405921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-type ATPases in Caenorhabditis and Drosophila: implications for evolution of the P-type ATPase subunit families with special reference to the Na,K-ATPase and H,K-ATPase subgroup.
    Okamura H; Yasuhara JC; Fambrough DM; Takeyasu K
    J Membr Biol; 2003 Jan; 191(1):13-24. PubMed ID: 12532273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid secretion and the H,K ATPase of stomach.
    Prinz C; Kajimura M; Scott D; Helander H; Shin J; Besancon M; Bamberg K; Hersey S; Sachs G
    Yale J Biol Med; 1992; 65(6):577-96. PubMed ID: 1341065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the gastric H,K ATPase for ion pathways and inhibitor binding sites.
    Munson K; Law RJ; Sachs G
    Biochemistry; 2007 May; 46(18):5398-417. PubMed ID: 17425287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H+-ATPase activity in selective disruption of H+-K+-ATPase alpha 1 gene of mice under normal and K-depleted conditions.
    Nakamura S
    J Lab Clin Med; 2006 Jan; 147(1):45-51. PubMed ID: 16443004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The conformation of H,K-ATPase determines the nucleoside triphosphate (NTP) selectivity for active proton transport.
    Reenstra WW; Crothers J; Forte JG
    Biochemistry; 2007 Sep; 46(35):10145-52. PubMed ID: 17696364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel indanyl-substituted imidazo[1,2-a]pyridines as potent reversible inhibitors of the gastric H+/K+-ATPase.
    Zimmermann PJ; Buhr W; Brehm C; Palmer AM; Feth MP; Senn-Bilfinger J; Simon WA
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5374-8. PubMed ID: 17723299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mutations in M4 of the gastric H+,K+-ATPase on inhibition kinetics of SCH28080.
    Munson KB; Lambrecht N; Sachs G
    Biochemistry; 2000 Mar; 39(11):2997-3004. PubMed ID: 10715120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.